Biomedical subjects

Huadong Tang

Publications and source records attributed to Huadong Tang.

12 recordsLinked to original sources

PubMed2006

Highly active copper-based catalyst for atom transfer radical polymerization.

Atom transfer radical polymerization (ATRP) generally requires a catalyst/initiator molar ratio of 0.1 to 1 and catalyst/monomer molar ratio of 0.001 to 0.01 (i.e., catalyst concentration: 1000-10,000 ppm versus monomer). Herein, we report a new copper-based complex CuBr/N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) as a versatile and highly active catalyst for acrylic, methacrylic, and styrenic monomers. The catalyst mediated ATRP at a catalyst/initiator molar ratio of 0.005 and produced polymers with well-controlled molecular weights and low polydispersities. ATRP occurred even at a catalyst/initiator molar ratio as low as 0.001 with copper concentration in the produced polymers as low as 6-8 ppm (catalyst/monomer molar ratio = 10(-5)). The catalyst structures were studied by X-ray diffraction and NMR spectroscopy. The activator CuIBr/TPEN existed in solution as binuclear and mononuclear complexes in equilibrium but as a binuclear complex in its single crystals. The deactivator CuIIBr2/TPEN complex was mononuclear. High stability and appropriate KATRP (ATRP equilibrium constant) were found crucial for the catalyst working under high dilution or in coordinating solvents/monomers. This provides guidance for further design of highly active ATRP catalysts.

Journal Article↗

PubMed2006

A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.

Allometrically scaled data sets (138 compounds) used for predicting human clearance were obtained from the literature. Our analyses of these data have led to four observations. (1) The current data do not provide strong evidence that systemic clearance (CL(s); n = 102) is more predictable than apparent oral clearance (CL(po); n = 24), but caution needs to be applied because of potential CL(po) prediction error caused by differences in bioavailability across species. (2) CL(s) of proteins (n = 10) can be more accurately predicted than that of non-protein chemicals (n = 102). (3) CL(s) is more predictable for compounds eliminated by renal or biliary excretion (n = 33) than by metabolism (n = 57). (4) CL(s) predictability for hepatically eliminated compounds followed the order: high CL (n = 11) > intermediate CL (n = 17) > low CL (n = 29). All examples of large vertical allometry (% error of prediction greater than 1000%) occurred only when predicting human CL(s) of drugs having very low CL(s). A qualitative analysis revealed the application of two potential rules for predicting the occurrence of large vertical allometry: (1) ratio of unbound fraction of drug in plasma (f(u)) between rats and humans greater than 5; (2) C logP greater than 2. Metabolic elimination could also serve as an additional indicator for expecting large vertical allometry.

Biological Availability↗

PubMed2006

On the observed large interspecies overprediction of human clearance ("vertical allometry") of UCN-01: further support for a proposed model based on plasma protein binding.

The prediction of a human clearance (CL) value for UCN-01, an extreme example of vertical allometry (a large overprediction by allometric scaling), was examined using commonly used simple allometry and the "rule of exponents," as well as a newly proposed model, which quantitatively incorporates plasma protein-binding information from rats and humans. Simple allometry and the rule of exponents were shown to overpredict the human CL value of UCN-01 by about 5000- and 1750-fold, respectively. The new model incorporating the ratio of fraction unbound between rats and humans improved the prediction by about 20-fold compared to the rule of exponents. The model is expected to improve if a more accurate measurement of the unbound fraction in human plasma is obtained. The prediction of volume distribution for UCN-01 by allometric scaling was also shown to be dependent on the difference of fraction unbound between animal species and humans. In summary, plasma protein binding has been demonstrated to be an important measure for interspecies scaling of pharmacokinetics.

Animals↗

PubMed2005

Deficiency of disulfide bonds facilitating fibrillogenesis of endostatin.

Endostatin is an endogenous inhibitor of tumor angiogenesis and tumor growth. It has two pairs of disulfide bonds in a unique nested pattern, which play a key role in its native conformation, stability, and activity. Here, we constructed a disulfide-deficient variant of endostatin, endo-all-Ala, to examine the effects of the two disulfide bonds on fibrillogenesis of endostatin under nondenaturing conditions. Based on thioflavin T fluorescence, atomic force microscopy, far-UV circular dichroism, and Fourier transform infrared spectroscopy, we found that endo-all-Ala, which has a higher alpha-helical content compared with wild type, is prone to forming fibrils in a pH-dependent manner. Subsequently, more hydrophobic patches with a lower stability of endo-all-Ala were observed when compared with wild type, which possibly contributes to the propensity of amyloid formation of endo-all-Ala. To our surprise, the significant increase of the alpha-helical content in endostatin induced by trifluoroethanol can also facilitate fibril formation. In addition, the cytotoxicity of fibrillar aggregates of endo-all-Ala, which were generated at different stages of the fibril formation process, was evaluated by cell viability assay. The results indicate that the cytotoxicity is not due to the fibrils but rather due to the granular aggregates of endo-all-Ala. Moreover, endostatin was interestingly found to be reduced by glutathione at physiological concentrations. Our present work not only elucidates the correlation between the existence of disulfide bonds and the fibril formation of endostatin but also may provide some insights into the structural and functional basis of endostatin in Alzheimer disease brains.

Alanine↗

PubMed2005

A novel model for prediction of human drug clearance by allometric scaling.

Sixty-one sets of clearance (CL) values in animal species were allometrically scaled for predicting human clearance. Unbound fractions (f(u)) of drug in plasma in rats and humans were obtained from the literature. A model was developed to predict human CL: CL=33.35 ml/min x (a/Rf(u))(0.770), where Rf(u) is the f(u) ratio between rats and humans and a is the coefficient obtained from allometric scaling. The new model was compared with simple allometric scaling and the "rule of exponents" (ROE). Results indicated that the new model provided better predictability for human values of CL than did ROE. It is especially significant that for the first time the proposed model improves the prediction of CL for drugs illustrating large vertical allometry.

1-Octanol↗

PubMed2005

Poly(ionic liquid)s: a new material with enhanced and fast CO2 absorption.

Novel sorbent and membrane materials for CO2 separation, poly(ionic liquid)s made from ionic liquid monomers, poly[p-vinylbenzyltrimethyl ammonium tetrafluoroborate](P[VBTMA][BF4]) and poly[2-(methacryloyloxy)ethyltrimethylamnonium tetrafluoroborate](P[MATMA][BF4]) have absorption capacities 7.6 and 6.0 times of those of room-temperature ionic liquids, e.g.[bmim][BF4], respectively, with reversible and fast sorption and desorption.

Boron Compounds↗

PubMed2005

Accuracy of allometrically predicted pharmacokinetic parameters in humans: role of species selection.

A general equation was derived, which directly describes the mathematical relationship between the allometrically predicted pharmacokinetic (PK) parameters in humans and the body weights of animal species (along with their corresponding measured PK parameters). It was shown, with use of the derived equation, that the predicted values in humans, based on combinations of animal species commonly used in allometry, are heavily dependent on certain species, for example, the dog. In contrast, parameter values from the rat made no contribution to the predicted human values, as long as the rat was not the smallest species used. Monte Carlo simulations were further performed to examine the species or weight dependence. The cost-effective combinations of animal species, in terms of number and species type, were theoretically examined through simulations. Finally, literature data demonstrated the species or weight dependence predicted from the equation and as illustrated through the Monte Carlo simulations. Appreciation of this species or weight dependence should guide researchers in selecting animal species and designing optimal experiments in the application of allometric scaling.

Animals↗

PubMed2005

A mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance.

The functionality of the correction factors, maximum life-span potential (MLP), and brain weight (BrW) used in allometry is mathematically described. Correction by MLP or BrW is equivalent to a multiplication of some constants by the predicted values in humans from simple allometry, but they have no relationship to measured pharmacokinetic parameters in the animal species. The values of these constants (F(MLP) or F(BrW)) were calculated for some commonly used combinations of animal species. For all combinations of animal species, the value of F(BrW) is always greater than that of F(MLP) with a fold-increase of about 1.3 to 1.9. Different combinations of species give different values of F(BrW) and F(MLP). In addition, the role of correction factors (MLP and BrW) or the "rule of exponents" (ROE) was evaluated. An intrinsic defect in using correction factors or ROE was revealed; different study designs will produce significantly different prediction results. However, ROE may still serve as a useful practical approach in predicting human CL since it was derived from real observations and has been applied to many examples.

Animals↗

PubMed2005

Fibrillogenesis of apomyoglobin facilitated by aggregation sequence of yeast Sup35 in various regions.

To examine the effect of aggregation sequence QGGYQQQYNP from yeast Sup35 on fibril formation of sperm whale apomyoglobin (apoMb), we constructed several mutants via substitution. Urea-induced unfolding of apoMb confirms that the substitution of the aggregation sequence does not significantly affect the stability of the mutants compared to wild type (WT) at pH 4.2. Under this condition, however, despite the difference in rate most apoMb mutants form fibrils more readily than WT with distinct morphology. These results suggest that the aggregation sequence facilitates fibril assembly of apoMb at acidic pH in vitro and this facilitation depends on the regions replaced.

Amino Acid Sequence↗

PubMed2004

Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig.

The purpose of this study is to characterize the distribution pattern of P-gp protein levels along the entire GI tract in the Yucatan micropig, which is being developed as a model for human drug bioavailability. Small and large intestines were freshly obtained and divided into about 37 segments and 10 segments, respectively (ca., 1 foot/segment). Epithelial cells from the small intestine were obtained by an elution method; whereas, a scraping method was applied to the large intestine. Total cellular protein was isolated from the epithelial cells. Western blot analysis using P-gp antibody showed that the amount of P-gp protein increased distally from the duodenum to the ileum over approximately a 10-fold range. P-gp protein in the large intestine was present at a higher level in the central portion, but the absolute amount was much less than what was found in the small intestine.

ATP Binding Cassette Transporter, Subfamily B, Mem↗

PubMed2002

A novel aryl amide-bridged ladderlike polymethylsiloxane synthesized by an amido H-bonding self-assembled template.

A novel soluble aryl amide-bridged ladderlike polymethylsiloxane (A-LPMS) was synthesized by stepwise coupling polymerization on the basis of amido H-bonding self-assembling template from monomer N,N'-bis(3-methyldiethoxylsilylpropyl)-[4,4'-oxybis(benzyl amide)]. The monomer was prepared in a high yield by the hydrosilylation reaction of template agent N,N'-diallyl-[4,4'-oxybis(benzyl amide)] with methyldiethoxysilane in the presence of dicyclopentadienylplatinum dichloride (Cp(2)PtCl(2)) as catalyst. A variety of techniques including (1)H NMR, (13)C NMR, (29)Si NMR, FTIR, XRD, DSC, and, especially, static and dynamic light scattering and viscosimetry were combined to confirm the presence of the ordered ladderlike structure of polymer A-LPMS.

Journal Article↗

PubMedDate not supplied

Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers.

"Stealth" nanoparticles made from polymer micelles have been widely explored as drug carriers for targeted drug delivery. High stability (i.e., low critical micelle concentration (CMC)) is required for their intravenous applications. Herein, we present a "core-surface cross-linking" concept to greatly enhance nanoparticle's stability: amphiphilic brush copolymers form core-surface cross-linked micelles (nanoparticles) (SCNs). The amphiphilic brush copolymers consisted of hydrophobic poly(epsilon-caprolactone) (PCL) and hydrophilic poly(ethylene glycol) (PEG) or poly(2-(N,N-dimethylamino)ethyl methacrylate) (PDMA) chains were synthesized by macromonomer copolymerization method and used to demonstrate this concept. The resulting SCNs were about 100 times more stable than micelles from corresponding amphiphilic block copolymers. The size and surface properties of the SCNs could be easily tailored by the copolymer's compositions.

Cross-Linking Reagents↗